CBD is one of the substances that naturally occur in cannabis. In June 2018, The Food and Drug Administration (FDA) approved the use of a specific cannabidiol CBD product to treat two specific types of epilepsy. Recent research has also suggests that CBD may also help reduce the symptoms of menopause.
Cannabidiol is a chemical found in cannabis plants, and it is that cannabidiol oil that may help alleviate the symptoms of menopause. Menopause disrupts the endocannabinoid system in the body, and CBD manipulates the chemicals involved in this system.
The endocannabinoid system plays a role in many of our bodily functions:
- Mood regulation
- Immune functions
- Sleep memory
- Fertility and reproduction
- Temperature regulation
Research indicates that CBD helps with some of the most common symptoms of menopause such as mood changes, sleep disturbances, and even bone density. Yes, some studies found CBD interacts with a cannabinoid receptor that may play a role in bone density loss; this loss often occurs during menopause. Recent studies suggest that inflammation might be one of the most significant causes of bone degeneration – CBD can help reduce inflammation, relax muscles, and calm nerves.
While research has only really started to understand how the endocannabinoid system works and the role it plays in so many different health conditions, with medical facilities now more able to do real research on cannabis due to some law changes, we are all anxiously awaiting more studies.
Stop by any Doctor Green dispensary location and speak to a trained caring budtender about how CBD oil may benefit you!
Makara-Studzińśka, M. T., Kryś-Noszczyk, K. M., & Jakiel, G. (2014). Epidemiology of the symptoms of menopause – an intercontinental review. Przeglad menopauzalny = Menopause review, 13(3), 203–211.
Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E., Mechoulam, R., and Feldman, M. (2000). The Nonpsychoactive Cannabis Constituent Cannabidiol is an Oral Anti-arthritic Therapeutic in Murine Collagen-induced Arthritis. Proceedings of the National Academy of Sciences of the United States of America, 97(17), 9561–9566.
Sales, A.J., Crestani, C.C., Guimaraes, F.S., Joca, S.R.L. (2018). Antidepressant-like Effect Induced by Cannabidiol is Dependent on Brain Serotonin Levels. Progress in Neuro-psychopharmacology & Psychiatry, 30(86), 255-261.
Mundy, G.R. (2007). Osteoporosis and Inflammation. International Life Sciences Institute, 141-151.
Murillo-Rodríguez, E., Sarro-Ramírez, A., Sánchez, D., Mijangos-Moreno, S., Tejeda-Padrón, A., Poot-Aké, A.,Arias-Carrión, O. (2014). Potential effects of cannabidiol as a wake-promoting agent. Current neuropharmacology, 12(3), 269–272.
Linares, I., Guimaraes, F. S., Eckeli, A., Crippa, A., Zuardi, A. W., Souza, J., … Crippa, J. (2018). No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Frontiers in pharmacology, 9, 315.
Beale, C., Broyd, S. J., Chye, Y., Suo, C., Schira, M., Galettis, P., … Solowij, N. (2018). Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. Cannabis and cannabinoid research, 3(1), 94–107.